The largest database of trusted experimental protocols

8 protocols using recombinant mouse ifn β

1

Molecular Targeting in Inflammatory Processes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dimethyl fumarate (DMF) (242926) and 4-octyl itaconate (4-OI) (SML2338) were dissolved in dimethyl sulfoxide (DMSO) (D8418), all purchased from Sigma. Baricitinib (7222) was purchased from R&D and also dissolved in DMSO. Recombinant mouse IFN-β was purchased from BioLegend (581304). High molecular weight poly(I:C) (tlrl-pic) was purchased from Invivogen. LPS from E. coli (ALX-581-010-L002) was purchased from Enzo Life Sciences for in vitro experiments. LPS from E. coli (L4524) and heparin (SRE-0027) were purchased from Sigma for in vivo experiments. 1H1 anti-TF antibody was a kind gift from Dr Helen Bettencourt (Genentech, Inc. South San Francisco, CA)46 . Cells were transfected (to activate caspase-11) using FuGENE HD (Promega).
+ Open protocol
+ Expand
2

Neonatal Murine Brain Cell Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The brains of 1 to 2 days old neonatal mice were prepared and transferred into Hanks Balanced Salt Solution (HBSS, ThermoFisher) containing 10 mM HEPES (ThermoFisher). After removal of the meninges, brains were minced, washed and incubated for 25 min in HBSS + 10 mM HEPES with 0.5 mg/ml papain (Sigma-Aldrich) and 10 μg/ml DNAse (Roche Diagnostics). Cells were washed again in BME medium (Life Technologies), dissociated and then plated at a density of 3 × 105 cells/ml and cultured in BME media supplemented with 10% FCS and penicillin/streptomycin. Cells were used for analyses after 21 days of culture and contained 20–30% microglia and 60–70% astrocytes. Cells were stimulated with LPS (0.1 µg/ml, Sigma-Aldrich) and U0126 (10 µM, Sigma-Aldrich) or with 1–1000 U/ml recombinant mouse IFNβ (BioLegend) for 24 h before ADP-ribosylation assays.
+ Open protocol
+ Expand
3

Quantifying Type I IFN Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
ISRE-L929 cells (54 (link)) were seeded at a density of 1 × 105 cells/well in a 96-well tissue culture plate in DMEM with 10% FBS, penicillin, and streptomycin, and cultured overnight at 37°C, 5% CO2 to allow them to adhere. Media was removed, and cells were incubated with supernatant from BMDCs or BMDMs stimulated with LPS or alginate and Pf4, as described elsewhere in the Methods section. To quantify type I IFN production, a twofold serially diluted standard curve of recombinant mouse IFN-β (BioLegend, Cat. No. 581309), starting at 1000 pg/ml, was used. ISRE-L929 cells were incubated with cells or protein standard for 9 hours at 37°C, 5% CO2. Cell supernatant was removed and Bright-Glo Reagent (Promega, Cat. No. E2610) was added to lyse cells for 2 min. Relative luminescent units were detected using a Spark microplate reader (Tecan).
+ Open protocol
+ Expand
4

Osteoclastogenesis Assay with RAW 264.7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Osteoclastogenesis assay was performed with RAW 264.7 cells (1.5*104 cells per well in a 24-well plate) that were incubated with 30 ng/ml RANKL (Peprotech, Israel) for 5 days. RANKL-treated cells were also treated with Zol and/or Dex, recombinant mouse IFN-β (0.25 or 2.5 ng/ml, Biolegend), or anti-IFN-β antibodies (2 μg/ml, Abcam, United Kingdom) for the first 2 days of incubation and then washed. RANKL was supplemented after washing.
+ Open protocol
+ Expand
5

Murine Embryonic Fibroblast Isolation and Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
pMEFs were generated from six different WT and SK1−/− embryos and frozen stocks generated at passage 3. Mice were used in accordance with animal ethics 181/12 approved by the SA Pathology/CALHN animal ethics committee. All MEF cultures were used in infection studies within 2 weeks of thawing. Individual studies were verified in at least two different pMEF cultures. Cells were treated in culture for 15–20 min with recombinant mouse IFN-β (Biolegend, San Diego, CA, USA) or pretreated for 90 min with 5 μM SK1-I (Enzo Life Sciences, Farmingdale, NY, USA) prior to stimulation with IFN-β. HEK293 cells expressing control or SK1 shRNA were generated following lentivirus transduction and selection as previously described.44 (link) Cells were passaged in tetracycline-free media (Dulbecco's modified Eagles medium (DMEM) with 10% (v/v) fetal calf serum) to minimise basal shRNA expression.
+ Open protocol
+ Expand
6

Generation and Characterization of STING Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
We generated a mouse monoclonal antibody that recognized an epitope within amino acids 322-339 of human STING and within amino acids 321-338 of mouse STING (Fig. S2A-D). A polyclonal antibody against phospho-S365 of mouse STING was generated in rabbits and affinity-purified (Fig. S2E). Polyclonal antibodies against mouse STING, Igα, Igβ, class I MHC heavy chain, and class II MHC α chain were generated in rabbits. An anti-SEL1L polyclonal antibody was also generated in rabbits and affinity-purified. The following antibodies were purchased: XBP1s (Cell Signaling), HRD1 (Abgent), HRD1 (Proteintech), p97 (Fitzgerald), μ (SouthernBiotech), κ (SouthernBiotech), phospho-Syk (Cell Signaling), Syk (Cell Signaling), phospho-Igα (Cell Signaling), TCL1 (Cell Signaling), cleaved caspase 3 (Cell Signaling), cleaved caspase 7 (Cell Signaling), calnexin (Proteintech), and actin (Sigma). LPS and digitonin were purchased from Sigma. Recombinant mouse IFNβ and TNFα were procured from Biolegend. Kifunensine and MG132 were purchased from Cayman. 3’3’-cGAMP was chemically synthesized as described previously.28 (link)
+ Open protocol
+ Expand
7

Splenic B cell activation by interferon-beta

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive splenic B cells were purified using a negative selection magnetically assisted cell sorting kit (Miltenyi Biotech) according to the manufacturer’s protocol and cultured in IMDM (Gibco, Invitrogen) containing 10% heat-inactivated FBS (Wisent) and supplemented with penicillin-streptomycin (Life Technologies). Purified B cells were then incubated by themselves, with the parasite at a multiplicity of infection (MOI) of 5 or 10, or with 10 ng/mL mouse recombinant IFN-β (BioLegend) at 37°C and 5% CO2 for the duration specified. For experiments assessing the necessity of direct contact for B cell activation, transwell permeable membrane inserts (Corning) with a pore size of 0.4 μm and a polyethylene terephthalate (PET) membrane were used to separate total B cell populations or B cell subpopulations, and only the cells in the top compartment were exposed to PKH67-labeled parasite.
+ Open protocol
+ Expand
8

Splenic B cell activation by interferon-beta

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive splenic B cells were purified using a negative selection magnetically assisted cell sorting kit (Miltenyi Biotech) according to the manufacturer’s protocol and cultured in IMDM (Gibco, Invitrogen) containing 10% heat-inactivated FBS (Wisent) and supplemented with penicillin-streptomycin (Life Technologies). Purified B cells were then incubated by themselves, with the parasite at a multiplicity of infection (MOI) of 5 or 10, or with 10 ng/mL mouse recombinant IFN-β (BioLegend) at 37°C and 5% CO2 for the duration specified. For experiments assessing the necessity of direct contact for B cell activation, transwell permeable membrane inserts (Corning) with a pore size of 0.4 μm and a polyethylene terephthalate (PET) membrane were used to separate total B cell populations or B cell subpopulations, and only the cells in the top compartment were exposed to PKH67-labeled parasite.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!